Abstract

THE MONOCLONAL ANTIBODY WITH ABUNDANT AILMENT TREATMENT OF: OMALIZUMAB MAKES SPONTANEOUS DISEASE HIV: AIDS

Sahil Srivastava*, Amit bind, Saurabh Gupta, Shweta Singh, Sumit Kumar Maurya, Nidhi Gupta, Vishwakarma Kuldeep Nandlal and Anurag Singh

ABSTRACT

Recent studies show that Omalizumab, a recombinant antibody that has been used to treat a variety of diseases including severe allergic asthma, urticaria, and atopic dermatitis, can now be used to make HIV positive patients asymptomatic with proper administration of Omalizumab in the subcutaneous layer of the body. HIV is definitely linked to all other types of pulmonary diseases, pulmonary symptoms, and immunological alterations; there is allergic inflammation and hyper-responsiveness in the respiratory region, but this can be treated and managed with Omalizumab injective therapy.

Keywords: Omalizumab, HIV, Antiretroviral, Therapy, Symptoms, Asymptomatic.